Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Peither, A."'
Autor:
Peither, Thomas1 tpeither@gmp-verlag.de, Lakonig, Stefan2, Oschmann, Rainer3, Bicane, Fatima3, Brückner, Thomas4, Häusler, Heribert5, Schmitt, Siegfried6, Waldöfner, Norbert7, Follmann, Martin8
Publikováno v:
Pharmazeutische Industrie (Pharmind). Mar2024, Vol. 86 Issue 3, p224-228. 4p.
Autor:
Peither, Thomas1 thomas.peither@gmp-publishing.com
Publikováno v:
Pharmazeutische Industrie (Pharmind). 2017, Vol. 79 Issue 2, p269-273. 5p.
Autor:
Lucero, María Luisa1 (AUTHOR), Peither, Armin2 (AUTHOR), Ledo, Francisco1 (AUTHOR) fledo@faes.es
Publikováno v:
Drug & Chemical Toxicology. Oct2015, Vol. 38 Issue 4, p460-468. 9p.
Publikováno v:
GMP Review. Jan2018, Vol. 16 Issue 4, p8-10. 3p.
Autor:
Girling, A.E., Pascoe, D., Janssen, C.R., Peither, A., Wenzel, A., Schäfer, H., Neumeier, B., Mitchell, G.C., Taylor, E.J., Maund, S.J., Lay, J.P., Jüttner, I., Crossland, N.O., Stephenson, R.R., Persoone, G.
Publikováno v:
In Ecotoxicology and Environmental Safety February 2000 45(2):148-176
Autor:
Pascoe, D. *, Wenzel, A., Janssen, C., Girling, A.E., Jüttner, I., Fliedner, A., Blockwell, S.J., Maund, S.J. †, Taylor, E.J., Diedrich, M., Persoone, G., Verhelst, P., Stephenson, R.R., Crossland, N.O., Mitchell, G.C., Pearson, N., Tattersfield, L. †, Lay, J.-P., Peither, A., Neumeier, B., Velletti, A.-R.
Publikováno v:
In Water Research 2000 34(8):2323-2329
Autor:
Thomas Schmidt, John P. Sumpter, Armin Peither, Klaus J. Weber, Ulrich Memmert, Andreas Hartmann, Roland Burri
Publikováno v:
Environmental Toxicology and Chemistry / Setac
Diclofenac (DCF) is a widely used nonsteroidal anti-inflammatory drug that is regularly detected in surface waters. To support a robust aquatic risk assessment, two early life stage (ELS) tests, compliant with the Organisation for Economic Co-operati
Erscheinungsjahr in einem Chronogramm. - Vorlageform des Erscheinungsvermerks: Vetero-Pragæ in Aula Regia, apud Wolffgangum Wickhart, Archi-Episc: Typogr.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a536773e825bb9c2a92b505208c92277
Publikováno v:
Drug and chemical toxicology. 38(4)
Bilastine is a new oral selective, non-sedating histamine H1 antagonist for the symptomatic treatment of allergic rhinoconjunctivitis and urticaria. The European Medicines Agency requires an Environmental Risk Assessment (ERA) for all novel medicines
Autor:
I Jüttner, AE Girling, J.P. Lay, B Neumeier, Guido Persoone, SJ Maund, EJ Taylor, GC Mitchell, N.O. Crossland, Colin R. Janssen, A Peither, David Pascoe, H Schäfer, RR Stephenson, A Wenzel
Publikováno v:
Ecotoxicology and Environmental Safety. 45:148-176
This article presents a summary of a collaborative research program involving five European research groups, that was partly funded by the European Commission under its Environmental Research Program. The objective of the program was to develop aquat